Burkina Faso Five-Year Evaluation of the Global Fund (GF5YE): Study Area 3 – Health Impact Sharing experiences in linking M&E to research linking M&E to.

Slides:



Advertisements
Similar presentations
Five -Year (5YE) Evaluation of the Global Fund
Advertisements

Parallel Session on Monitoring and Evaluation to Inform Action and Set Direction fro Research Five -Year (5YE) Evaluation of the Global Fund Tuesday, 18.
Framework for Operations and Implementation Research in Health
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
Global Alliance for Vaccines and Immunization. n An Alliance u Traditional and new partners u Public and private sector n Partners have in common: u Situation.
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Development Policy Lending Retrospective Customization, Flexibility, and Results OPCS, Country Economics.
CARMEN Policy Observatory and Dialogue Proposal Presentation to the CARMEN Directing Board Meeting San Juan, Puerto Rico 30 June 2003.
February Dakar, Senegal
Restructuring the Cancer Programs and Task Force Workgroups.
Family Planning/HIV Integration in a Large PEPFAR HIV Program – the ZPCT II Experience Prisca Kasonde MD, MMed, MPH Director Technical Support, ZPCT II/FHI.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
PRIVATE HEALTH SECTOR FOR QUALITY HEALTH CARE PRIVATE HEALTH SECTOR Trusted Partner in the delivery of Quality Healthcare Dr. Samwel Ogillo Program Manager.
METHODOLOGY FOR THE REVIEW/EVALUATION OF POLICY DOCUMENTS By Kwami DADJI, Health Officer HIV/AIDS, TB, Malaria & OID African Union Commission.
Cancer Education and Cultural Awareness Project (CECAP)
MEASURE Evaluation M&E and Advocacy Tools in the response to the Emergency Declaration.
Antibiotic Policy in Ghana; the way forward
Comprehensive M&E Systems
I NTRODUCTION TO B ASIC D ATA A NALYSIS AND I NTERPRETATION FOR H EALTH P ROGRAMS.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Sudan Presentation IGAD Regional Workshop for Global Fund Application.
MINISTRY OF COMMUNITY DEVELOPMENT MOTHER AND CHILD HEALTH MRS. ELIKA KAMIJI CHIEF EPI OFFICER IMPLEMENTATION OF GAPPD: ZAMBIAN EXPERIENCE Global Immunization.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
1 TB/HIV Project in the Philippines Yumiko Yanase.
A South Asia multi-country Global Fund Project Round 9 Title : Reducing the impact of HIV on men who have sex with men and transgender populations in South.
HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.
National Framework for GFATM Round 7 proposal Dr Rajendra Pant MBBS,MCPS,MPH Deputy Director National Center for AIDS and STD Control Kathmandu Nepal.
Unit 8: Uses and Dissemination of HIV Sentinel Surveillance Data #3-8-1.
The Global Fund- structure, function and evolution February 18, 2008.
IAS Members Working Together for a Stronger Health Workforce IAS General Members and Policy Meeting Sydney, 24 th July 2007.
Evidence and Information for Policy Health Metrics Network Strengthening Country-Level and Global Tracking of Health Outcomes.
In-country preparation and application of the Gender Assessment Tool – Supporting the Gender Assessment before, during and after the process Kibibi M.
Unit 10. Monitoring and evaluation
Toolkit for Mainstreaming HIV and AIDS in the Education Sector Guidelines for Development Cooperation Agencies.
INDEPTH Effectiveness and Safety studies of antimalarials in Africa (INESS ) IMPLEMENTATION SO FAR Aziza Mwisongo INDEPTH AGM PUNE, INDIA October 2009.
Introduction to Evaluation. Objectives Introduce the five categories of evaluation that can be used to plan and assess ACSM activities. Demonstrate how.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
Short Programme Review on Child Health Experience from Sri Lanka Family Health Bureau Ministry of Health Sri Lanka 1 Regional Programme Managers Meeting.
Involvement of community-based organizations in the fight against Tuberculosis and TB/VIH co-infection in Burkina Faso Dr Fodé SIMAGA
Joint Bi-Annual HIV/AIDS Review, 2008 Blue Pearl Hotel, Ubungo Plaza November 2008.
Global Advocacy Working Group Second report back.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Group 1 Presentation: HIV Testing in TB Patients and ART Provision.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Strategy for the assessment of information on DDT John Githure.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
Downloaded from Partnership for Implementation of workplace Programs Emmanuel Alhassan NACA ICASA, Abuja,
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Unit 9: Evaluating a Public Health Surveillance System #1-9-1.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
Third Joint Bi-Annual Review of the HIV Response in Tanzania October 2008 Assessment of Progress on Implementation of Milestones from the Second Joint.
Global Fund: Contributions to the Global Health Workforce 2 – 3 February 2012 Irish Forum for Global Health Conference.
NFM: Modular Template Measurement Framework: Modules, Interventions and Indicators LFA M&E Training February
1 The UN Perspective UNAIDS Trinidad & Tobago Tenth PANCAP Annual General Meeting, November 2, 2010 The AIDS Response in the Post-Earthquake Reconstruction.
HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August
Strengthening Integration between RMNCH and HIV services Nuhu Yaqub WHO Tanzania.
Main achievements and further developments 2006 and beyond: Overcoming HIV/AIDS epidemic in Ukraine (programme (programme supported by the Global Fund)
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
WHO Estonia country office Marge Reinap Head of WHO Country Office in Estonia.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Technical Evaluation Reference Group (TERG) of the Global Fund TERG Update Prof Rolf Korte, Chair of TERG Prof Rose Leke, Vice-Chair of TERG Fifteenth.
GLOBAL PREVENTION COALITION
Introduction Acknowledgments Identified need Project objective
Illustrative Cluster Detection and Response Strategy
How are programmes specifically designed using collected data?
Presentation transcript:

Burkina Faso Five-Year Evaluation of the Global Fund (GF5YE): Study Area 3 – Health Impact Sharing experiences in linking M&E to research linking M&E to research Meda N, Simaga F, Tiendrebeogo AJ, Soudré R on Behalf of MACRO/WHO/ Burkina Faso GF5YE Evaluation Team

The National Reference Group for NHA and 2 research institutions selected (IRSS, GREFSaD) 13 Districts selected, 1 per health region, 3 urban, 10 rural, with high (6), medium (3), & low (4) exposition to support/interventions National Health Accounts ( ) National record reviews (HIV, Tb, Malaria, General) Secondary analysis of national surveys (HIV, Tb, Malaria, General) Primary data collection: DCA Facility-based surveys Community-based surveys CBO interventions inventory CBO interventions inventory

Values of GF5YE – Linkages with Research Evidence of poor quality of the routine health information system Evidence of poor quality of the routine health information system for the monitoring of VCT, ARV procurement & treatment, PMTCT, etc. Need of technical support (tools, training, archiving) Establish a research-based observatory of universal access Low access to PMTCT services (only 14%) Low access to PMTCT services (only 14%): Use coverage of target population to follow the programme instead of number of facilities with PMTCT Introduce in round 9 grant operational research on barriers and facilitators to access PMTCT services by comparing good and bad performers health facilities Rising incidence of TB and malaria Rising incidence of TB and malaria Better detection rate of TB? Better surveillance of malaria?

Gaps in Linking Evaluation Outcomes with Research – How to Address Them? Gaps In-depth analysis of the huge amount of data sets gathered not yet occurred (only imposed indicators have been computed) In-depth description and analysis of the impact on health system indicators not yet done Distribution by disease, coverage, and quality of CBO devoted to the fight against HIV, Tb & Malaria unclear? How to Address Them? Support for further analysis of datasets and publications Study the added value of CBO in the fight against HIV, Tb & Malaria?

Specific Recommendations – Enhance the Link between M&E and Research further analysis Data sets gathered need further analysis to properly answer the basic evaluation questions. report key research questions The report of GF5YE in Burkina will provide a solid platform for evidence-based policy-making and advocacy in fund-raising (future GF rounds or other partners) and will raise key research questions to explore Operational research has to be funded Operational research has to be funded to address research questions raised by GF5YE findings (low access to PMTCT, rising incidence of malaria and Tb, effectiveness of ARV treatment, lack of CBO in malaria and TB programmes,.)

Acknowledgements Global Fund to Fight HIV/AIDS, Tb & Malaria WHO country office and headquarter MACRO international consultants Burkina Ministry of Health/Cabinet CCM/Burkina Task Force members SP/CNLS (NAC secretariat) Research groups and their field workers Community and health facilities surveyed